DW71177, CAS 2241311-72-6

Product Description: DW71177 is a novel [1,2,4]triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor, and can be used for study of acute myeloid leukemia[1].

Applications: COVID-19-immunoregulation

Formula: C20H28N6O2

References: [1]Ali I, et al. DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia. Eur J Med Chem. Published online December 16, 2023.

CAS Number: 2241311-72-6

Molecular Weight: 384.48

Compound Purity: 97.70

Research Area: Inflammation/Immunology

Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)

Target: Epigenetic Reader Domain

• SKU: MEXHY-162088-100
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-162088-100
• Green Labware: No
• Package Unit: 100 mg
• Quantity Unit: STK